Two Sigma Securities’s Lisata Therapeutics LSTA Stock Holding History

Two Sigma Securities’s Portfolio LSTA Stock Details LSTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,217	Closed	-$10K	–	2894
2022 Q2	$10K	Buy	+1,217	New	+$10K	﹤0.01%	2053
2021 Q4	–	Sell	-1,796	Closed	-$33K	–	1829
2021 Q3	$33K	Buy	+1,796	New	+$35.2K	﹤0.01%	1424
2016 Q2	–	Sell	-112	Closed	-$13K	–	477
2016 Q1	$13K	Buy	+112	New	+$11K	0.02%	253
2015 Q4	–	Sell	-116	Closed	-$26K	–	332
2015 Q3	$26K	Sell	116 -108	-48%	-$27.1K	0.04%	175
2015 Q2	$63K	Buy	+224	New	+$83.2K	0.11%	127

Other funds holding LSTA

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Cook Wealth Raleigh, North Carolina $206M AUM 4.73% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Two Sigma Securities's LSTA Position: Q3 2022 in Review

Two Sigma Securities sold out of Lisata Therapeutics (LSTA) in Q3 2022, closing a stake of 1,217 shares — an estimated $10K sold.

Two Sigma Securities first reported a position in LSTA in Q2 2015 and held it in 5 quarters. The position peaked at $63K in Q2 2015. 22 funds tracked by Wall St. Rank hold LSTA as of Q3 2022.

Two Sigma Securities reported no remaining Lisata Therapeutics position as of Q3 2022 after selling out during the quarter.
Two Sigma Securities sold 1,217 Lisata Therapeutics shares in Q3 2022, an estimated $10K.
Two Sigma Securities first reported a position in Lisata Therapeutics in Q2 2015 and held it in 5 quarters.
Two Sigma Securities's Lisata Therapeutics position peaked at $63K in Q2 2015.
22 funds tracked by Wall St. Rank held Lisata Therapeutics as of Q3 2022.

Based on Two Sigma Securities's 13F filing for Q3 2022, filed 14 Nov 2022.